Interferon alpha‐2b as therapy for patients with Ph '‐positive chronic myelogenous leukemia
G Alimena, E Morra, M Lazzarino… - European Journal of …, 1990 - Wiley Online Library
We treated 114 ph1+ chronic myeloid leukemia (CML) patients, 105 of whom were in
chronic phase (CP) and 9 in accelerated phase (AP), with interferon alpha‐2b (IFN α‐2b) at …
chronic phase (CP) and 9 in accelerated phase (AP), with interferon alpha‐2b (IFN α‐2b) at …
[引用][C] Interferon alpha-2b as therapy for patients with Ph1 positive chronic myelogenous leukemia
A Giuliana, M Enrica, M Lazzarino, M Enrico… - EUROPEAN JOURNAL …, 1990 - iris.unipv.it
Interferon alpha-2b as therapy for patients with Ph1 positive chronic myelogenous leukemia
IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano …
IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano …
Interferon alpha-2b as therapy for patients with Ph+ chronic myelogenous leukemia.
G Alimena, E Morra, M Lazzarino, A Liberati… - EUROPEAN …, 1990 - iris.uniroma1.it
We treated 114 Ph'+ chronic myeloid leukemia (CML) patients, 105 of whom were in chronic
phase (CP) and 9 in accelerated phase (AP), with interferon alpha-2b (IFN alpha-2b) at …
phase (CP) and 9 in accelerated phase (AP), with interferon alpha-2b (IFN alpha-2b) at …
Interferon alpha-2b as therapy for patients with Ph'-positive chronic myelogenous leukemia.
G Alimena, E Morra, M Lazzarino… - European Journal of …, 1990 - europepmc.org
We treated 114 Ph'+ chronic myeloid leukemia (CML) patients, 105 of whom were in chronic
phase (CP) and 9 in accelerated phase (AP), with interferon alpha-2b (IFN alpha-2b) at …
phase (CP) and 9 in accelerated phase (AP), with interferon alpha-2b (IFN alpha-2b) at …
Interferon alpha-2b as therapy for patients with Ph'-positive chronic myelogenous leukemia
G Alimena, E Morra, M Lazzarino… - European journal …, 1990 - pubmed.ncbi.nlm.nih.gov
We treated 114 Ph'+ chronic myeloid leukemia (CML) patients, 105 of whom were in chronic
phase (CP) and 9 in accelerated phase (AP), with interferon alpha-2b (IFN alpha-2b) at …
phase (CP) and 9 in accelerated phase (AP), with interferon alpha-2b (IFN alpha-2b) at …
Interferon alpha‐2b as therapy for patients with Ph '‐positive chronic myelogenous leukemia
G Alimena, E Morra, M Lazzarino… - EUROPEAN …, 1990 - research.unipg.it
We treated 114 Ph'+ chronic myeloid leukemia (CML) patients, 105 of whom were in chronic
phase (CP) and 9 in accelerated phase (AP), with interferon alpha-2b (IFN alpha-2b) at …
phase (CP) and 9 in accelerated phase (AP), with interferon alpha-2b (IFN alpha-2b) at …